Chimerix: Funding, Investors & Team (Aug 2026)
At Chimerix, our goal is to create drugs that significantly prolong and improve the lives of people with life-threatening illnesses. We are committed to solving gaps in the therapeutic paradigm with a focus on oncology.
Chimerix has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Nov 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Chimerix Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Chimerix Funding Rounds
Chimerix Founders and Leadership Team
Contact details for the Chimerix team: 1 of 1 has an email address on file.
Start 14-day free trial →Chimerix Funding Compared to Other Biotechnology Startups
Chimerix's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Chimerix in Biotechnology and Durham
Companies Similar to Chimerix
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Chimerix Funding FAQs
What does Chimerix do?
At Chimerix, our goal is to create drugs that significantly prolong and improve the lives of people with life-threatening illnesses. We are committed to solving gaps in the therapeutic paradigm with a focus on oncology.
How much funding has Chimerix raised?
Chimerix has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Nov 2022.
When did Chimerix last raise funding?
Chimerix's most recent funding round on record is an undisclosed round of $2.0M, announced in Nov 2022.
Who is the CEO of Chimerix?
Mike Sherman is listed as CEO at Chimerix.
Where is Chimerix headquartered?
Chimerix is based in Durham, North Carolina, United States.
How many employees does Chimerix have?
Chimerix is in the 101-250 employee band.
How does Chimerix's funding compare to other Biotechnology startups?
Chimerix's latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Chimerix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Chimerix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.